Antioxidant enzymes in erythrocytes from hypertension patients receiving lisinopril monotherapy or combined lisinopril plus simvastatin therapy

Biomeditsinskaya Khimiya

Volumn 57, Issue 3, 2011, Pages 335-342

  Kosenko, E A ^a   Suslikov, A V ^b   Venediktovd, N I ^a   Kaminsky, Y G ^a  

^a INSTITUTE OF THEORETICAL AND EXPERIMENTAL BIOPHYSICS   (Russian Federation)

^b RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

Author keywords

Antioxidant enzymes; Catalase; Erythrocyte; Glutathione peroxidase; Lisinopril; Simvastatin

Indexed keywords

ANTIOXIDANT; HYPOCHOLESTEROLEMIC AGENT; LISINOPRIL; OXIDOREDUCTASE; SIMVASTATIN;

ARTICLE; DRUG COMBINATION; ENZYMOLOGY; ERYTHROCYTE; FEMALE; HUMAN; HYPERTENSION; MALE; METABOLISM;

ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; DRUG THERAPY, COMBINATION; ERYTHROCYTES; FEMALE; HUMANS; HYPERTENSION; LISINOPRIL; MALE; OXIDOREDUCTASES; SIMVASTATIN;

EID: 80052921606     PISSN: 23106905     EISSN: None     Source Type: Journal    
DOI: 10.18097/pbmc20115703335     Document Type: Article

References (23)

1. Abuja P.M., Albertini R. (2001) Clin. Chim. Acta, 306, 1-17.
2. John S., Schmieder R.E. (2003) Curr. Hypertens. Rep., 5, 199-207.
3. Maselli R., Grembiale R.D., Pelaia G., Cuda G. (2002) Monaldi Arch. Chest. Dis. 57, 180-181
4. Brzeszczynska J., Pieniazek A., Gwozdzinski L., Gwozdzinski K., Jegier A. (2008) Appl. Physiol. Nutr. Metab, 33, 1223-1231.
5. Broncel M., Koter-Michalak M., Chojnowska-Jezierska J. (2006) Przegl. Lek., 63, 738-742.
6. Spósito A.C., Mansur A.P., Coelho O.R, Nicolau J.C., Ramires J.A. (1999) Am. J. Cardiol, 83, 1497-1499.
7. de Cavanagh E.M., Inserra F., Ferder L., Fraga C.G. (2000) Am. J. Physiol. Regul. Integr. Comp. Physiol, 278, R572-R577.
8. Kosenko E., Kaminsky Y., Kaminsky A., Valencia M., Lee L., Hermenegildo C., Felipo V. (1997) Free Radie. Res., 27, 637-644.
9. Beauchamp C., Fridovich I. (1971) Anal. Biochem, 44, 276-287.
10. Aebi H.E. (1984) in: Methods of enzymatic analysis, V.3 (H.U. Bergmeyer, ed.) Wiley, New York, pp. 273-286.
11. Goldberg D.M., Spooner R.J. (1984) in: Methods of enzymatic analysis, V.3 (H.U. Bergmeyer, ed.) Wiley, New York, pp. 259-265.
12. Kosenko E., Venediktova N., Kaminsky Y, Montoliu C., Felipo V. (2003) Brain Res, 981, 193-200.
13. Rubin R., Farber J.L. (1984) Arch. Biochem. Biophys, 228, 450-459.
14. Djordjević V.B., Pavlović D., PejovićM., Cvetković T., Leciæ N., Deljanin-IlićM. (1997) Clin. Nephrol, 47, 243-247.
15. Djordjević VB., Grubor-Lajsić G., Jovanovic-Galović A., PavlovićD., Cvetkovič T., PejovićM., LecićN. (1998) J. Environ. Pathol. Toxicol. Oncol, 17, 277-280.
16. de Cavanagh E.M., Perder L., Carrasquedo F., Scrivo D., Wassermann A., Fraga CG, Inserra F. (1999) Am. J. Kidney Dis, 34, 445-455.
17. Khan B. V, Sola S., Lauten W.B., Natarajan R., Hooper W.C., Menon R.G., Lerakis S., Helmy T. (2004) Diabetes Care, 27, 1712-1715.
18. Djordjević VB., Cosić V, Pavlović D., Vlahović P., Jevtović T., Kocić G., Savić V. (2000) Ren. Fail, 22, 535-544.
19. de Cavanagh E.M., Fraga CG., Perder L., Inserra F. (1997) Am. J. Physiol, 272, R514-R518.
20. Kowalski J., Pawlicki L., Grycewicz J., Biaszczyk J., Irzmańiski R., Ceglinæiski T., Kowalczyk E., Liban-Gaika B. (2005) Wiad Lek., 58, 275-279.
21. Sola S., Mir M.Q., Lerakis S., Tandon N., Khan B. V. (2006) J. Am. Coll. Cardiol, 47, 332-337.
22. Kowalski J., Olejniczak J., Błaszczyk J., Błaszczyk- Suszyńska J., Kowalski M., Petecka E., Kedziora J. (2003) Pol. Merkur. Lekarski, 14, 285-288.
23. Passi S., Stancato A., Aleo E., Dmitrieva A., Littarru G.P. (2003) Biofactors, 18, 113-124.